TLOG (TetraLogic Pharmaceuticals) Change In Receivables: $0.00 Mil (TTM As of Sep. 2016)


What is TetraLogic Pharmaceuticals Change In Receivables?

TetraLogic Pharmaceuticals TLOG Change In Receivables is $0.00 Mil as of Sep. 2016.

TetraLogic Pharmaceuticals's change in receivables for the quarter that ended in Sep. 2016 was $0.00 Mil. It means TetraLogic Pharmaceuticals's Accounts Receivable stayed the same from Jun. 2016 to Sep. 2016 .

TetraLogic Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2015 was $0.00 Mil. It means TetraLogic Pharmaceuticals's Accounts Receivable stayed the same from Dec. 2014 to Dec. 2015 .

TetraLogic Pharmaceuticals's Accounts Receivable for the quarter that ended in Sep. 2016 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. TetraLogic Pharmaceuticals's liquidation value for the three months ended in Sep. 2016 was $-67.84 Mil.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

TetraLogic Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2016 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, TetraLogic Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

TetraLogic Pharmaceuticals's liquidation value for the quarter that ended in Sep. 2016 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=5.885-73.726+0.75 * 0+0.5 * 0
=-67.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Change In Receivables Related Terms

TetraLogic Pharmaceuticals Change In Receivables Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Change In Receivables Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Change In Receivables
0.00 0.00 0.00 0.00 0.00

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TetraLogic Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.00 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Change In Receivables of $0.00 Mil as of Sep. 2016. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Change In Receivables too high?
TetraLogic Pharmaceuticals' current Change In Receivables is $0.00 Mil.
How does TetraLogic Pharmaceuticals' Change In Receivables compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Change In Receivables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Change In Receivables of $0.00 Mil. The current Change In Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Change In Receivables is $0.00 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.